Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.310
-0.090 (-6.43%)
At close: Nov 20, 2024, 4:00 PM
1.319
+0.009 (0.67%)
After-hours: Nov 20, 2024, 4:03 PM EST
Alzamend Neuro Employees
As of April 30, 2024, Alzamend Neuro had 7 total employees, including 4 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,056,342
Market Cap
5.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cutera | 430 |
Zhongchao | 142 |
Syros Pharmaceuticals | 68 |
Intelligent Bio Solutions | 50 |
Ainos | 46 |
Viracta Therapeutics | 40 |
Organovo Holdings | 20 |
NLS Pharmaceutics AG | 7 |
ALZN News
- 3 months ago - Alzamend Neuro Stock Jumps After Post Traumatic Stress Disorder Study Pact: Details - Benzinga
- 3 months ago - Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder - Business Wire
- 7 months ago - Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program - Business Wire
- 1 year ago - Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's - Business Wire
- 1 year ago - Ault Alliance Announces Alzamend Neuro Has Initiated Its Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer's Type - Business Wire
- 2 years ago - BitNile Holdings Contemplates Exchange Offer to Acquire Shares of Its Common Stock - Business Wire
- 2 years ago - In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Stephan Jackman, CEO Alzamend Neuro, Inc. - Accesswire
- 2 years ago - BitNile Holdings Reports Third Quarter 2022 Financial Results, Including Revenue of $100 Million for the Nine Months Ended September 30, 2022, up 124% from the Prior Year's Nine-Month Period - Business Wire